Why Is ATAI Life Sciences Stock Trading Lower On Monday? Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a favorable safety profile.
What's going on in today's pre-market session Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices were higher.
Top movers in Friday's after hours session Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Which stocks are experiencing notable movement on Tuesday? Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Let's uncover which stocks are experiencing notable gaps during today's session. Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data Atai and Beckley report that a single dose of BPL-003 reduced depression symptoms significantly and safely in treatment-resistant patients.
Get insights into the top gainers and losers of Tuesday's pre-market session. Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
Atai Life Sciences Stock Soars To 3-Month High As Depression Study Yields Promising Results: Retail Bulls Cheer Atai Life Sciences shares surged 11.4% after Beckley Psytech reported encouraging Phase 2a results of its depression treatment
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.
Wondering what's happening in today's after-hours session? Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care? AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental health care.
